logo
Select company
Select metric
Ticker Information

Ticker

ATYR

Company Name

ATYR PHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ATYR PHARMA INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ATYR - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -66.64M0%$ 0
3/31/2025$ -63.41M0%$ 0
12/31/2024$ -64.02M-27243.83%$ 235K
9/30/2024$ -63.82M-27155.74%$ 235K
6/30/2024$ -57.9M-9846.43%$ 588K
3/31/2024$ -53.93M-9171.6%$ 588K
12/31/2023$ -50.39M-14274.5%$ 353K
9/30/2023$ -43.15M-401.81%$ 10.74M
6/30/2023$ -45.05M-433.8%$ 10.39M
3/31/2023$ -45.14M-434.59%$ 10.39M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for ATYR PHARMA INC is calculated as follows: EBIT [ $ -17.27M ] / Revenues [ $ 8.55M ]
(=) EBIT % [ -202.02% ]

ATYR - EBIT Margin, Last 5 years

-27243.83%

Minimum

Dec 31, 2024

-155.18%

Maximum

Dec 31, 2020

-6685.46%

Average

-1186.14%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.54% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.54%
median9.01%
std23.96%